255 related articles for article (PubMed ID: 23221866)
61. Relief of Pain-Depressed Behavior in Rats by Activation of D1-Like Dopamine Receptors.
Lazenka MF; Freitas KC; Henck S; Negus SS
J Pharmacol Exp Ther; 2017 Jul; 362(1):14-23. PubMed ID: 28411257
[TBL] [Abstract][Full Text] [Related]
62. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
Graham DL; Hoppenot R; Hendryx A; Self DW
Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
[TBL] [Abstract][Full Text] [Related]
63. Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors.
Ferger B; Kropf W; Kuschinsky K
Psychopharmacology (Berl); 1994 Mar; 114(2):297-308. PubMed ID: 7838923
[TBL] [Abstract][Full Text] [Related]
64. SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism.
Adachi K; Ikeda H; Hasegawa M; Nakamura S; Waddington JL; Koshikawa N
Eur J Pharmacol; 1999 Feb; 367(2-3):143-9. PubMed ID: 10078986
[TBL] [Abstract][Full Text] [Related]
65. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
[TBL] [Abstract][Full Text] [Related]
66. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
Gong W; Neill DB; Lynn M; Justice JB
Neuroscience; 1999; 93(4):1349-58. PubMed ID: 10501459
[TBL] [Abstract][Full Text] [Related]
67. Enhancement of the acoustic startle response in rats by the dopamine D1 receptor agonist SKF 82958.
Meloni EG; Davis M
Psychopharmacology (Berl); 1999 Jun; 144(4):373-80. PubMed ID: 10435410
[TBL] [Abstract][Full Text] [Related]
68. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.
Mayorga AJ; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
Psychopharmacology (Berl); 1999 Mar; 143(1):72-81. PubMed ID: 10227082
[TBL] [Abstract][Full Text] [Related]
69. Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW 373U86 and SNC 80: 3. Facilitation of D1 and D2 responses in unilaterally 6-hydroxydopamine-lesioned rats.
Pinna A; Di Chiara G
Behav Pharmacol; 1998 Feb; 9(1):15-21. PubMed ID: 9832944
[TBL] [Abstract][Full Text] [Related]
70. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
71. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro.
Momiyama T; Todo N; Sasa M
Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652
[TBL] [Abstract][Full Text] [Related]
72. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
Paul ML; Graybiel AM; David JC; Robertson HA
J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
[TBL] [Abstract][Full Text] [Related]
73. The role of dopamine in reinforcement: changes in reinforcement sensitivity induced by D1-type, D2-type, and nonselective dopamine receptor agonists.
Bratcher NA; Farmer-Dougan V; Dougan JD; Heidenreich BA; Garris PA
J Exp Anal Behav; 2005 Nov; 84(3):371-99. PubMed ID: 16596971
[TBL] [Abstract][Full Text] [Related]
74. Effects of dopamine D1 and D2 receptor agonists on environmental enrichment attenuated sucrose cue reactivity in rats.
Glueck E; Ginder D; Hyde J; North K; Grimm JW
Psychopharmacology (Berl); 2017 Mar; 234(5):815-825. PubMed ID: 28032125
[TBL] [Abstract][Full Text] [Related]
75. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
Jutkiewicz EM; Bergman J
J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
[TBL] [Abstract][Full Text] [Related]
76. Dopamine D1 receptor in the NAc shell is involved in delayed emergence from isoflurane anesthesia in aged mice.
Zhang Y; Gui H; Hu L; Li C; Zhang J; Liang X
Brain Behav; 2021 Jan; 11(1):e01913. PubMed ID: 33094567
[TBL] [Abstract][Full Text] [Related]
77. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal-Beliveau BS; Joyce JN
Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
[TBL] [Abstract][Full Text] [Related]
78. Amphetamine reinstates polydipsia induced by chronic exposure to quinpirole, a dopaminergic D2 agonist, in rats.
Fraioli S; Cioli I; Nencini P
Behav Brain Res; 1997 Dec; 89(1-2):199-215. PubMed ID: 9475627
[TBL] [Abstract][Full Text] [Related]
79. Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
Lublin H; Gerlach J; Peacock L
Clin Neuropharmacol; 1992 Dec; 15(6):448-58. PubMed ID: 1362136
[TBL] [Abstract][Full Text] [Related]
80. Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats.
Wilkerson A; Levin ED
Neuroscience; 1999 Mar; 89(3):743-9. PubMed ID: 10199609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
